Literature DB >> 7633444

Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus.

G Jansen1, D Bächner, M Coerwinkel, N Wormskamp, H Hameister, B Wieringa.   

Abstract

The diverse biological consequences of size-expansion of the unstable (CTG)n repeat in the myotonic dystrophy protein kinase (DM-PK) gene at chromosome region 19q13.3, are still poorly understood. Abnormal (CTG)n length may affect either DM-PK mRNA fate or function, or alternatively, compromise gene transcription by distortion of chromatin configuration. In the latter model involvement of neighbouring genes in DM upon extreme expansion of the repeat cannot be discarded as a possibility and should be studied further. Here we report on the elucidation of the complete genomic structure and expression pattern of the mouse DMR-N9 gene (called 59 gene in humans), which is at 1.1 kbp upstream of the DM-PK gene. This gene contains five exons spanning 7 kbp and codes for a protein of 650 amino acids. Two regions of the predicted protein show significant homology to WD repeats, highly conserved amino acid sequences found in a family of proteins engaged in signal transduction or cell regulatory functions. The start site of transcription has been determined and we have identified putative transcription factor binding sequences in a 400 bp putative promoter area immediately upstream of the transcribed unit. Northern blotting analysis and RNA in situ hybridization revealed ubiquitous low expression in all tissues of the mouse embryo and enhanced expression in adult brain and testis. The onset of transcription is phased early in mouse embryogenesis, before or at day 9.5 of gestation. From day 14.5 onwards DMR-N9 mRNAs were detected in all neural tissues, especially in the telencephalon and mesencephalon. Later, mRNA presence is evident in distinct tubules of the mature testis, restricted to secondary spermatocytes of stages VIII to XII of the spermatogenic proliferation cycle. We conclude that the DMR-N9 gene is a candidate for being involved in the manifestation of mental and testicular symptoms in severe cases of DM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633444     DOI: 10.1093/hmg/4.5.843

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

Review 1.  Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Authors:  R P Junghans; A Ebralidze; B Tiwari
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

2.  The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.

Authors:  P Steinbach; D Gläser; W Vogel; M Wolf; S Schwemmle
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

Authors:  C Abbruzzese; R Krahe; M Liguori; D Tessarolo; M J Siciliano; T Ashizawa; M Giacanelli
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

4.  Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells.

Authors:  A A Benders; P J Groenen; F T Oerlemans; J H Veerkamp; B Wieringa
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 5.  Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive.

Authors:  P N Strong; B S Brewster
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 7.  Myotonic dystrophy: molecular windows on a complex etiology.

Authors:  Z Korade-Mirnics; P Babitzke; E Hoffman
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

8.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.

Authors:  L T Timchenko; J W Miller; N A Timchenko; D R DeVore; K V Datar; L Lin; R Roberts; C T Caskey; M S Swanson
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

Review 9.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 10.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.